Delcath Systems, Inc. logo

Delcath Systems, Inc.

NASDAQ:DCTH

Overview | Financials
Company Name Delcath Systems, Inc.
Symbol DCTH
Currency USD
Price 14.84
Market Cap 496,139,784
Dividend Yield 0%
52-week-range 5.3 - 16.97
Industry Medical Devices
Sector Healthcare
CEO Mr. Gerard J. Michel MBA, MS
Website https://www.delcath.com

An error occurred while fetching data.

About Delcath Systems, Inc.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and

Related Stocks

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

0.819 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

1.19 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

18.83 USD

Immunome, Inc. logo

Immunome, Inc.

IMNM

7.46 USD

Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc.

TARA

3.24 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

3.37 USD

Financials

Numbers are in millions USD

Numbers are in millions USD